Medications That Cause Diaphoresis

Antidepressants and Serotonergic Agents

The American Academy of Child and Adolescent Psychiatry recommends monitoring for diaphoresis as a common adverse effect of SSRIs and SNRIs, which directly cause diaphoresis through serotonergic mechanisms 1, 2.
Diaphoresis occurs both as an isolated side effect and as part of serotonin syndrome, which presents with the triad of mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity including diaphoresis, hypertension, tachycardia, and tachypnea 1.
The risk of serotonin syndrome is highest when SSRIs/SNRIs are combined with MAOIs, other antidepressants, tramadol, meperidine, methadone, fentanyl, stimulants, dextromethorphan, or metoclopramide 1, 2.

The American Academy of Child and Adolescent Psychiatry states that methylphenidate, amphetamines, dextroamphetamine, and lisdexamfetamine cause diaphoresis through sympathomimetic effects 5, 6.
These medications can also contribute to serotonin syndrome when combined with SSRIs or other serotonergic agents 1, 2.

The American Academy of Child and Adolescent Psychiatry recommends monitoring for diaphoresis in patients taking opioids, including morphine, methadone, meperidine, fentanyl, tramadol, oxycodone, and hydrocodone, particularly when combined with serotonergic medications leading to serotonin syndrome 1, 2.
Tramadol has particularly high serotonergic activity and poses significant risk for serotonin syndrome 1.

Patients on SSRIs/SNRIs for depression or anxiety are at baseline risk for diaphoresis from these medications, according to the American Heart Association, as stated in Circulation 1, 2.
The American College of Cardiology recommends sertraline as a safer alternative to citalopram or escitalopram regarding QTc prolongation, though all SSRIs can cause diaphoresis 2.

Monitor intensively for serotonin syndrome during the first 24-48 hours after starting any serotonergic combination or dose change, watching for confusion, agitation, tremor, diaphoresis, tachycardia, and hyperreflexia, as recommended by the American Academy of Child and Adolescent Psychiatry 1, 3.
Discontinue all serotonergic agents immediately if serotonin syndrome develops, provide supportive care with continuous cardiac monitoring, and consider benzodiazepines for symptom control, according to the American Academy of Child and Adolescent Psychiatry 1.